<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39390446</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature.</ArticleTitle><Pagination><StartPage>1139</StartPage><MedlinePgn>1139</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1139</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09967-w</ELocationID><Abstract><AbstractText>We investigate the emergence, mutation profile, and dissemination of SARS-CoV-2 lineage B.1.214.2, first identified in Belgium in January 2021. This variant, featuring a 3-amino acid insertion in the spike protein similar to the Omicron variant, was speculated to enhance transmissibility or immune evasion. Initially detected in international travelers, it substantially transmitted in Central Africa, Belgium, Switzerland, and France, peaking in April 2021. Our travel-aware phylogeographic analysis, incorporating travel history, estimated the origin to the Republic of the Congo, with primary European entry through France and Belgium, and multiple smaller introductions during the epidemic. We correlate its spread with human travel patterns and air passenger data. Further, upon reviewing national reports of SARS-CoV-2 outbreaks in Belgian nursing homes, we found this strain caused moderately severe outcomes (8.7% case fatality ratio). A distinct nasopharyngeal immune response was observed in elderly patients, characterized by 80% unique signatures, higher B- and T-cell activation, increased type I IFN signaling, and reduced NK, Th17, and complement system activation, compared to similar outbreaks. This unique immune response may explain the variant's epidemiological behavior and underscores the need for nasal vaccine strategies against emerging variants.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Holtz</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Université Paris Cité, Paris, France. andrew.holtz@pasteur.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Van Weyenbergh</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium. johan.vanweyenbergh@kuleuven.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Samuel L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuypers</LastName><ForeName>Lize</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University Hospitals Leuven, National Reference Centre for Respiratory Pathogens, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Toole</LastName><ForeName>Áine</ForeName><Initials>Á</Initials><AffiliationInfo><Affiliation>Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudas</LastName><ForeName>Gytis</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerdol</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potter</LastName><ForeName>Barney I</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntoumi</LastName><ForeName>Francine</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondation Congolaise Pour La Recherche Médicale, Brazzaville, Republic of Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mapanguy</LastName><ForeName>Claujens Chastel Mfoutou</ForeName><Initials>CCM</Initials><AffiliationInfo><Affiliation>Fondation Congolaise Pour La Recherche Médicale, Brazzaville, Republic of Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Sciences and Techniques, University Marien Ngouabi, Brazzaville, Republic of Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanmechelen</LastName><ForeName>Bert</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wawina-Bokalanga</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Holm</LastName><ForeName>Bram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Soraya Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soubotko</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Practice Heiberg, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Pottelbergh</LastName><ForeName>Gijs</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wollants</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermeersch</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University Hospitals Leuven, National Reference Centre for Respiratory Pathogens, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Ann-Sophie</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University Hospitals Leuven, National Reference Centre for Respiratory Pathogens, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory for Molecular Diagnostics, Jessa Hospital, Hasselt, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hasselt University, Hasselt, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Limburg Clinical Research Center, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obbels</LastName><ForeName>Dagmar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Ghent, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheeussen</LastName><ForeName>Veerle</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Antwerp University Hospital (UZA), Edegem, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Biochemistry and Laboratory of Medical Microbiology, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martens</LastName><ForeName>Geert</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, AZ Delta General Hospital, Roeselare, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gras</LastName><ForeName>Jérémie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut de Pathologie Et de Génétique, Gosselies, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhasselt</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laffut</LastName><ForeName>Wim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vael</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, KLINA General Hospital, Brasschaat, AZ, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goegebuer</LastName><ForeName>Truus</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>AZ Sint-Maarten, Mechelen, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Kant</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Switch Laboratory, VIB Center for Brain and Disease Research and Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousseau</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Switch Laboratory, VIB Center for Brain and Disease Research and Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schymkowitz</LastName><ForeName>Joost</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Switch Laboratory, VIB Center for Brain and Disease Research and Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Genomic Regulation, Barcelona Institute for Science and Technology, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Pompeu Fabra, 08002, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institució Catalana de Recerca I Estudis Avançats, 08010, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Genomic Regulation, Barcelona Institute for Science and Technology, 08003, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenseleers</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bours</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, CHU Liege, Liege, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>André</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rambaut</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellicour</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Maes</LastName><ForeName>Piet</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Durkin</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Baele</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI153044</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI162611</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI135995</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058974" MajorTopicYN="N">Phylogeography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Disease spread</Keyword><Keyword MajorTopicYN="N">Genomic epidemiology</Keyword><Keyword MajorTopicYN="N">Phylodynamics</Keyword><Keyword MajorTopicYN="N">Phylogeography</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>0</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39390446</ArticleId><ArticleId IdType="pmc">PMC11468156</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09967-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09967-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, Rangarajan ES, Pan A, Vanderheiden A, Suthar MS, et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020;11:6013. 10.1038/s41467-020-19808-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693302</ArticleId><ArticleId IdType="pubmed">33243994</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M, Woo HG. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Front Immunol. 2022;12:830527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8819067</ArticleId><ArticleId IdType="pubmed">35140714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W-T, Huang W-H, Liao T-L, Hsiao T-H, Chuang H-N, Liu P-Y. SARS-CoV-2 E484K Mutation Narrative Review: Epidemiology, Immune Escape, Clinical Implications, and Future Considerations. Infect Drug Resist. 2022;15:373–85. 10.2147/IDR.S344099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820839</ArticleId><ArticleId IdType="pubmed">35140483</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan TS, Toyoda M, Ode H, Barabona G, Hamana H, Kitamatsu M, Kishi H, Motozono C, Iwatani Y, Ueno T. Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike J Virol. 96:e01162–22. 10.1128/jvi.01162-22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9599599</ArticleId><ArticleId IdType="pubmed">36214577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C, Bhattacharya M, Sharma AR, Mallik B. Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein. Int J Biol Macromol. 2022;219:980–97. 10.1016/j.ijbiomac.2022.07.254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9359758</ArticleId><ArticleId IdType="pubmed">35952818</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19:409–24. 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdol M, Dishnica K, Giorgetti A. Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein. Virus Res. 2022;310:198674. 10.1016/j.virusres.2022.198674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743576</ArticleId><ArticleId IdType="pubmed">35021068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mfoutou Mapanguy CC, Batchi-Bouyou AL, Djontu JC, Pallerla SR, Ngoma CH, Linh LTK, Rachakonda S, Casadei N, Angelov A, Sonnabend M, et al. SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo. IJID Reg. 2022;3:106–13. 10.1016/j.ijregi.2022.03.009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8907106</ArticleId><ArticleId IdType="pubmed">35720148</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Toole Á, Scher E, Underwood A, Jackson B, Hill V, McCrone JT, Colquhoun R, Ruis C, Abu-Dahab K, Taylor B, et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021;7(2):veab064. 10.1093/ve/veab064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco JD, Hernandez-Alias X, Cianferoni D, Serrano L. In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species. PLOS Comput Biol. 2020;16:e1008450. 10.1371/journal.pcbi.1008450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746295</ArticleId><ArticleId IdType="pubmed">33284795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuypers L, Keyaerts E, Hong SL, Gorissen S, Menezes SM, Starick M, Van Elslande J, Weemaes M, Wawina-Bokalanga T, Marti-Carreras J, et al. Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks. Nat Aging. 2023;3:722–33. 10.1038/s43587-023-00421-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10275758</ArticleId><ArticleId IdType="pubmed">37217661</ArticleId></ArticleIdList></Reference><Reference><Citation>Welle (www.dw.com), D. Belgian researchers identify new coronavirus variant | DW | 29.03.2021. DW.COM. https://www.dw.com/en/belgian-researchers-identify-new-coronavirus-variant/a-57042412.</Citation></Reference><Reference><Citation>Montero-Blay A, Blanco JD, Rodriguez-Arce I, Lastrucci C, Piñero-Lambea C, Lluch-Senar M, Serrano L. Bacterial expression of a designed single-chain IL-10 prevents severe lung inflammation. Mol Syst Biol. 2023;19:e11037. 10.15252/msb.202211037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9834763</ArticleId><ArticleId IdType="pubmed">36598022</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado J, Radusky LG, Cianferoni D, Serrano L. FoldX 5.0: working with RNA, small molecules and a new graphical interface. Bioinformatics. 2019;35:4168–9. 10.1093/bioinformatics/btz184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792092</ArticleId><ArticleId IdType="pubmed">30874800</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12:7–8. 10.1038/nmeth.3213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428668</ArticleId><ArticleId IdType="pubmed">25549265</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger E, Vriend G. YASARA View—molecular graphics for all devices—from smartphones to workstations. Bioinformatics. 2014;30:2981–2. 10.1093/bioinformatics/btu426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4184264</ArticleId><ArticleId IdType="pubmed">24996895</ArticleId></ArticleIdList></Reference><Reference><Citation>Omasits U, Ahrens CH, Müller S, Wollscheid B. Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. 2014;30:884–6. 10.1093/bioinformatics/btt607.</Citation><ArticleIdList><ArticleId IdType="pubmed">24162465</ArticleId></ArticleIdList></Reference><Reference><Citation>FoldX web server: an online force field | Nucleic Acids Research | Oxford Academic https://academic.oup.com/nar/article/33/suppl_2/W382/2505499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1160148</ArticleId><ArticleId IdType="pubmed">15980494</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksamentov I, Roemer C, Hodcroft EB, Neher RA. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6:3773. 10.21105/joss.03773.</Citation></Reference><Reference><Citation>Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, Sagulenko P, Bedford T, Neher RA. NextStrain: Real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–3. 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagulenko P, Puller V, Neher RA. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol. 2018;4:vex042. 10.1093/ve/vex042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5758920</ArticleId><ArticleId IdType="pubmed">29340210</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, Von Haeseler A, Lanfear R, Teeling E. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:1530–4. 10.1093/molbev/msaa015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182206</ArticleId><ArticleId IdType="pubmed">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016;2:vew007. 10.1093/ve/vew007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4989882</ArticleId><ArticleId IdType="pubmed">27774300</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchene S, Lemey P, Stadler T, Ho SYW, Duchene DA, Dhanasekaran V, Baele G. Bayesian evaluation of temporal signal in measurably evolving populations. Mol Biol Evol. 2020;37:3363–79. 10.1093/molbev/msaa163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454806</ArticleId><ArticleId IdType="pubmed">32895707</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Lemey P, Baele G, Ayres DL, Drummond AJ, Rambaut A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4:vey016. 10.1093/ve/vey016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6007674</ArticleId><ArticleId IdType="pubmed">29942656</ArticleId></ArticleIdList></Reference><Reference><Citation>Baele G, Lemey P, Suchard MA. Genealogical working distributions for bayesian model testing with phylogenetic uncertainty. Syst Biol. 2016;65:250–64. 10.1093/sysbio/syv083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009437</ArticleId><ArticleId IdType="pubmed">26526428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SL, Lemey P, Suchard MA, Baele G. Bayesian Phylogeographic Analysis Incorporating Predictors and Individual Travel Histories in BEAST. Curr Protoc. 2021;1:e98. 10.1002/cpz1.98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8672455</ArticleId><ArticleId IdType="pubmed">33836121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemey P, Hong S, Hill V, Baele G, Poletto C, Colizza V, O’Toole A, McCrone JT, Andersen KG,  Worobey M, et al. (2020). Accommodating individual travel history, global mobility, and unsampled diversity in phylogeography: a SARS-CoV-2 case study. BioRxiv Prepr Serv Biol. 10.1101/2020.06.22.165464.</Citation></Reference><Reference><Citation>Beard R, Magee D, Suchard MA, Lemey P, Scotch M. Generalized linear models for identifying predictors of the evolutionary diffusion of viruses. AMIA Jt. Summits Transl. Sci Proc AMIA Jt Summits Transl Sci. 2014;2014:23–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333690</ArticleId><ArticleId IdType="pubmed">25717395</ArticleId></ArticleIdList></Reference><Reference><Citation>BlueDot: Outbreak Intelligence Platform BlueDot. https://bluedot.global/.</Citation></Reference><Reference><Citation>Minin VN, Suchard MA. Counting labeled transitions in continuous-time Markov models of evolution. J Math Biol. 2008;56:391–412. 10.1007/s00285-007-0120-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17874105</ArticleId></ArticleIdList></Reference><Reference><Citation>Baele G, Gill MS, Lemey P, Suchard MA. Hamiltonian Monte Carlo sampling to estimate past population dynamics using the skygrid coalescent model in a Bayesian phylogenetics framework. Wellcome Open Res. 2020;5:53. 10.12688/wellcomeopenres.15770.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7463299</ArticleId><ArticleId IdType="pubmed">32923688</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Syst Biol. 2018;67:901–4. 10.1093/sysbio/syy032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6101584</ArticleId><ArticleId IdType="pubmed">29718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Heled J, Bouckaert R. Looking for trees in the forest: Summary tree from posterior samples. BMC Evol Biol. 2013;13:221. 10.1186/1471-2148-13-221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3853548</ArticleId><ArticleId IdType="pubmed">24093883</ArticleId></ArticleIdList></Reference><Reference><Citation>Decru B, Van Elslande J, Steels S, Van Pottelbergh G, Godderis L, Van Holm B, Bossuyt X, Van Weyenbergh J, Maes P, Vermeersch P. IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers. Front Immunol. 2022;13:909910. 10.3389/fimmu.2022.909910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9241488</ArticleId><ArticleId IdType="pubmed">35784321</ArticleId></ArticleIdList></Reference><Reference><Citation>Quick J. (2020). nCoV-2019 sequencing protocol v1 10.17504/protocols.io.bbmuik6w.</Citation></Reference><Reference><Citation>Freed NE, Vlková M, Faisal MB, Silander OK. Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding. Biol Methods Protoc. 2020;5:bpaa014. 10.1093/biomethods/bpaa014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454405</ArticleId><ArticleId IdType="pubmed">33029559</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes SM, Braz M, Llorens-Rico V, Wauters J, Van Weyenbergh J. Endogenous IFNβ expression predicts outcome in critical patients with COVID-19. Lancet Microbe. 2021;2:e235–6. 10.1016/S2666-5247(21)00063-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009614</ArticleId><ArticleId IdType="pubmed">33817674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloréns-Rico V, Gregory AC, Van Weyenbergh J, Jansen S, Van Buyten T, Qian J, Braz M, Menezes SM, Van Mol P, Vanderbeke L, et al. Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host. Nat Commun. 2021;12:6243. 10.1038/s41467-021-26500-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556379</ArticleId><ArticleId IdType="pubmed">34716338</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukutani KF, Nascimento-Carvalho CM, Bouzas ML, Oliveira JR, Barral A, Dierckx T, Khouri R, Nakaya HI, Andrade BB, Van Weyenbergh J, et al. In situ Immune Signatures and Microbial Load at the Nasopharyngeal Interface in Children With Acute Respiratory Infection. Front Microbiol. 2018;9:2475. 10.3389/fmicb.2018.02475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238668</ArticleId><ArticleId IdType="pubmed">30473680</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, de Silva TI, Peacock SJ, Barclay WS, de Silva TI, Towers GJ, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21:162–77. 10.1038/s41579-022-00841-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Alouane T, Laamarti M, Essabbar A, Hakmi M, Bouricha EM, Chemao-Elfihri MW, Kartti S, Boumajdi N, Bendani H, Laamarti R, et al. Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the “Confined Virus”? Pathogens. 2020;9:829. 10.3390/pathogens9100829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600297</ArticleId><ArticleId IdType="pubmed">33050463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, McConkey GA, Zechner M, Klaric L, Griffiths F, et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023;617:764–8. 10.1038/s41586-023-06034-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10208981</ArticleId><ArticleId IdType="pubmed">37198478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GC, Restrepo MI, Harper N, Manoharan MS, Smith AM, Meunier JA, Sanchez-Reilly S, Ehsan A, Branum AP, Winter C, et al. Immunologic resilience and COVID-19 survival advantage. J Allergy Clin Immunol. 2021;148:1176–91. 10.1016/j.jaci.2021.08.021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425719</ArticleId><ArticleId IdType="pubmed">34508765</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, Debnath O, Thürmann L, Kurth F, Völker MT, et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38:970–9. 10.1038/s41587-020-0602-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32591762</ArticleId></ArticleIdList></Reference><Reference><Citation>Unterman A, Sumida TS, Nouri N, Yan X, Zhao AY, Gasque V, Schupp JC, Asashima H, Liu Y, Cosme C, et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat Commun. 2022;13:440. 10.1038/s41467-021-27716-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782894</ArticleId><ArticleId IdType="pubmed">35064122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H, San JE, Cotten M, Moir M, Tegomoh B, Mboowa G, Martin DP, Baxter C, Lambisia  AW, Diallo A. et al. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance. Science 2022;378:eabq5358. 10.1126/science.abq5358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9529057</ArticleId><ArticleId IdType="pubmed">36108049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson E, Giovanetti M, Tegally H, San JE, Lessells R, Cuadros D, Martin DP, Rasmussen DA, Zekri A-RN, Sangare AK, et al. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science. 2021;374:423–31. 10.1126/science.abj4336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613315</ArticleId><ArticleId IdType="pubmed">34672751</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisi NM, Dai B, Ibrahim M. Global Health Security amid COVID-19: Tanzanian government’s response to the COVID-19 Pandemic. BMC Public Health. 2023;23:205. 10.1186/s12889-023-14991-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9887238</ArticleId><ArticleId IdType="pubmed">36721158</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudas G, Hong SL, Potter BI, Calvignac-Spencer S, Niatou-Singa FS, Tombolomako TB, Fuh-Neba T, Vickos U, Ulrich M, Leendertz FH., et al. Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions. Nat Commun. 2021;12: 5769. 10.1038/s41467-021-26055-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486757</ArticleId><ArticleId IdType="pubmed">34599175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaleta T, Kern L, Hong SL, Hölzer M, Kochs G, Beer J, Schnepf D, Schwemmle M, Bollen N,  Kolb P,  et al. Antibody escape and global spread of SARS-CoV-2 lineage A.27. Nat Commun. 2022;13:1152. 10.1038/s41467-022-28766-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894356</ArticleId><ArticleId IdType="pubmed">35241661</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H, San JE, Cotten M, Moir M, Tegomoh B, Mboowa G, Martin DP, Baxter C, Lambisia  AW, Diallo A, et al. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance. Science 2022;378:eabq5358. 10.1126/science.abq5358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9529057</ArticleId><ArticleId IdType="pubmed">36108049</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603:679–86. 10.1038/s41586-022-04411-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Suñer C, Ouchi D, Mas MÀ, Lopez Alarcon R, Massot Mesquida M, Prat N, Bonet-Simó JM, Expósito Izquierdo M, Garcia Sánchez I, Rodoreda Noguerola S, et al. A retrospective cohort study of risk factors for mortality among nursing homes exposed to COVID-19 in Spain. Nat Aging. 2021;1:579–84. 10.1038/s43587-021-00079-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37117802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Human Genetic Effort COVID, Cobat A, Casanova J-L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603:587–98. 10.1038/s41586-022-04447-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Orlova E, Sozaeva L, Lévy R, James A, Schmitt MM, Ochoa S, Kareva M, Rodina Y, Gervais A, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021;218:e20210554. 10.1084/jem.20210554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077172</ArticleId><ArticleId IdType="pubmed">33890986</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, et al. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021;13:eabh2624. 10.1126/scitranslmed.abh2624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601717</ArticleId><ArticleId IdType="pubmed">34429372</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol EJ, Iwasaki A. (2022). Operation Nasal Vaccine—Lightning speed to counter COVID-19. Sci Immunol. 10.1126/sciimmunol.add9947.</Citation><ArticleIdList><ArticleId IdType="pubmed">35862488</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>